Post-earnings recap
Reported
Thu, Jul 31, 2025
EPS actual
$0.16
EPS est.
$0.18
EPS surprise
-11.11%
1-day move
+2.15%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Aurinia Pharmaceuticals reported an EPS of $0.16, which was below expectations, but the stock still rose by 2.15% following the announcement. This increase may reflect investor optimism or reaction to other factors not detailed in the earnings report. Without revenue figures or management commentary, the outlook remains unclear.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.16 | N/A | -11.11% |
| Revenue | — | N/A | — |
No transcript is on record for the earnings call, so the analysis is based solely on the numerical results.